Claudia Ponce Aportela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Claudia Ponce Aportela has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ariadna Herrera
Florida International University
2 shared publications - Asad Mirza
Department of Biomedical Engineering, Florida International University, Miami, FL, 33199, United States
2 shared publications - Sharan Ramaswamy
Florida International University
2 shared publications - Brittany A. Gonzalez
Department of Biomedical Engineering, Florida International University, Miami, FL 33174, USA
1 shared publication - Chia-Pei Denise Hsu
Department of Biomedical Engineering, Florida International University, Miami, FL 33174, USA
1 shared publication - Daniela Alvarado
Florida International University
1 shared publication
Latest Publications
- 12 April 2025
- Published by Springer Nature
- p. 291-307
Revolutionizing Pediatric Valve Replacement: The Future of Elastin-Rich Tissue-Engineered Solutions
- 12 April 2025
- Published by Springer Nature
- p. 291-307
Revolutionizing Pediatric Valve Replacement: The Future of Elastin-Rich Tissue-Engineered Solutions
- Open Access
- 20 October 2022
- Published by MDPI AG in Bioengineering
- Vol. 9 (10) , 587
Stem Cell-Secreted Allogeneic Elastin-Rich Matrix with Subsequent Decellularization for the Treatment of Critical Valve Diseases in the Young
Critical valve diseases in infants have a very poor prognosis for survival. Particularly challenging is for the valve replacement to support somatic growth. From a valve regenerative standpoint, bio-scaffolds have been extensively investigated recently. While bio-scaffold valves facilitate acute valve functionality, their xenogeneic properties eventually induce a hostile immune response. Our goal was to investigate if a bio-scaffold valve could be deposited with tissues derived from allogeneic stem cells, with a specific dynamic culture protocol to enhance the extracellular matrix (ECM) constituents, with subsequent stem cell removal. Porcine small intestinal submucosa (PSIS) tubular-shaped bio-scaffold valves were seeded with human bone marrow-derived mesenchymal stem cells (hBMMSCs), cultured statically for 8 days, and then exposed to oscillatory fluid-induced shear stresses for two weeks. The valves were then safely decellularized to remove the hBMMSCs while retaining their secreted ECM. This de novo ECM was found to include significantly higher (p < 0.05) levels of elastin compared to the ECM produced by the hBMMSCs under standard rotisserie culture. The elastin-rich valves consisted of ~8% elastin compared to the ~10% elastin composition of native heart valves. Allogeneic elastin promotes chemotaxis thereby accelerating regeneration and can support somatic growth by rapidly integrating with the host following implantation. As a proof-of-concept of accelerated regeneration, we found that valve interstitial cells (VICs) secreted significantly more (p < 0.05) collagen on the elastin-rich matrix compared to the raw PSIS bio-scaffold.
- 20 October 2022
- Published by MDPI AG in Bioengineering
- Vol. 9 (10) , 587
Open AccessStem Cell-Secreted Allogeneic Elastin-Rich Matrix with Subsequent Decellularization for the Treatment of Critical Valve Diseases in the Young
Critical valve diseases in infants have a very poor prognosis for survival. Particularly challenging is for the valve replacement to support somatic growth. From a valve regenerative standpoint, bio-scaffolds have been extensively investigated recently. While bio-scaffold valves facilitate acute valve functionality, their xenogeneic properties eventually induce a hostile immune response. Our goal was to investigate if a bio-scaffold valve could be deposited with tissues derived from allogeneic stem cells, with a specific dynamic culture protocol to enhance the extracellular matrix (ECM) constituents, with subsequent stem cell removal. Porcine small intestinal submucosa (PSIS) tubular-shaped bio-scaffold valves were seeded with human bone marrow-derived mesenchymal stem cells (hBMMSCs), cultured statically for 8 days, and then exposed to oscillatory fluid-induced shear stresses for two weeks. The valves were then safely decellularized to remove the hBMMSCs while retaining their secreted ECM. This de novo ECM was found to include significantly higher (p < 0.05) levels of elastin compared to the ECM produced by the hBMMSCs under standard rotisserie culture. The elastin-rich valves consisted of ~8% elastin compared to the ~10% elastin composition of native heart valves. Allogeneic elastin promotes chemotaxis thereby accelerating regeneration and can support somatic growth by rapidly integrating with the host following implantation. As a proof-of-concept of accelerated regeneration, we found that valve interstitial cells (VICs) secreted significantly more (p < 0.05) collagen on the elastin-rich matrix compared to the raw PSIS bio-scaffold.